You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 19, May 20, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •JAMA Report Video
 •Author in the Room® Teleconference
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent Insomnia

A Randomized Controlled Trial

Charles M. Morin, PhD; Annie Vallières, PhD; Bernard Guay, MD; Hans Ivers, PhD; Josée Savard, PhD; Chantal Mérette, PhD; Célyne Bastien, PhD; Lucie Baillargeon, MD

JAMA. 2009;301(19):2005-2015.

Context  Cognitive behavioral therapy (CBT) and hypnotic medications are efficacious for short-term treatment of insomnia, but few patients achieve complete remission with any single treatment. It is unclear whether combined or maintenance therapies would enhance outcome.

Objectives  To evaluate the added value of medication over CBT alone for acute treatment of insomnia and the effects of maintenance therapies on long-term outcome.

Design, Setting, and Patients  Prospective, randomized controlled trial involving 2-stage therapy for 160 adults with persistent insomnia treated at a university hospital sleep center in Canada between January 2002 and April 2005.

Interventions  Participants received CBT alone or CBT plus 10 mg/d (taken at bedtime) of zolpidem for an initial 6-week therapy, followed by extended 6-month therapy. Patients initially treated with CBT attended monthly maintenance CBT for 6 months or received no additional treatment and those initially treated with combined therapy (CBT plus 10 mg/d of zolpidem) continued with CBT plus intermittent use of zolpidem or CBT only.

Main Outcome Measures  Sleep onset latency, time awake after sleep onset, total sleep time, and sleep efficiency derived from daily diaries (primary outcomes); treatment response and remission rates derived from the Insomnia Severity Index (secondary outcomes).

Results  Cognitive behavioral therapy used singly or in combination with zolpidem produced significant improvements in sleep latency, time awake after sleep onset, and sleep efficiency during initial therapy (all P<.001); a larger increase of sleep time was obtained with the combined approach (P = .04). Both CBT alone and CBT plus zolpidem produced similar rates of treatment responders (60% [45/75] vs 61% [45/74], respectively; P = .84) and treatment remissions (39% [29/75] vs 44% [33/74], respectively; P = .52) with the 6-week acute treatment, but combined therapy produced a higher remission rate compared with CBT alone during the 6-month extended therapy phase and the 6-month follow-up period (56% [43/74 and 32/59] vs 43% [34/75 and 28/68]; P = .05). The best long-term outcome was obtained with patients treated with combined therapy initially, followed by CBT alone, as evidenced by higher remission rates at the 6-month follow-up compared with patients who continued to take zolpidem during extended therapy (68% [20/30] vs 42% [12/29]; P = .04).

Conclusion  In patients with persistent insomnia, the addition of medication to CBT produced added benefits during acute therapy, but long-term outcome was optimized when medication is discontinued during maintenance CBT.

Trial Registration  clinicaltrials.gov Identifier: NCT00042146


Author Affiliations: École de Psychologie (Drs Morin, Vallières, Ivers, Savard, and Bastien), Centre de Recherche Université Laval/Robert-Giffard (Drs Morin, Vallières, Guay, Mérette, and Bastien), and Département de Médecine Familiale (Dr Baillargeon), Université Laval, Québec, Québec, Canada; Institut Universitaire en Santé Mentale de Québec, Québec, Canada (Dr Guay); Centre de Recherche en Cancérologie, Hôpital Hôtel-Dieu de Québec, Québec, Canada (Dr Savard); and Unité de Médecine Familiale, Pavillon CHUL, Québec, Québec, Canada (Dr Baillargeon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Cognitive Behavioral Therapy Alone and With Medication for Persistent Insomnia

JAMA. ;302():1053-1053.
FULL TEXT  

Cognitive Behavioral Therapy Alone and With Medication for Persistent Insomnia
, , and
JAMA. ;302():1053-1053.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive Behavioral Therapy Alone and With Medication for Persistent Insomnia
Jindal
JAMA 2009;302:1053-1053.
FULL TEXT  

Cognitive Behavioral Therapy Alone and With Medication for Persistent Insomnia
Yang et al.
JAMA 2009;302:1053-1053.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.